HROW Q1 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$48M+38.3% YoY

Gross Profit

$32M67.5% margin

Operating Income

-$11M-23.5% margin

Net Income

-$18M-37.2% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-28.4%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$19M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$364M

Total Liabilities

$308M

Stockholders' Equity

$56M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$35M	+38.3%
Gross Profit	$32M	$24M	+34.4%
Operating Income	-$11M	-$7M	-62.1%
Net Income	-$18M	-$14M	-31.1%

Revenue Segments

Other Products

$956,00092%

Other Revenue

$86,0008%